AZATHIOPRIN COPYFARM 50 mg tabletti, kalvopäällysteinen 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

azathioprin copyfarm 50 mg tabletti, kalvopäällysteinen

copyfarm a/s - azathioprinum - tabletti, kalvopäällysteinen - 50 mg - atsatiopriini

MELOXICAM COPYFARM 7.5 mg tabletti 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

meloxicam copyfarm 7.5 mg tabletti

copyfarm a/s - meloxicamum - tabletti - 7.5 mg - meloksikaami

MELOXICAM COPYFARM 15 mg tabletti 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

meloxicam copyfarm 15 mg tabletti

copyfarm a/s - meloxicamum - tabletti - 15 mg - meloksikaami

TRAMADOL COPYFARM 100 mg depotkapseli 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

tramadol copyfarm 100 mg depotkapseli

copyfarm a/s - tramadoli hydrochloridum - depotkapseli - 100 mg - tramadoli

TRAMADOL COPYFARM 150 mg depotkapseli 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

tramadol copyfarm 150 mg depotkapseli

copyfarm a/s - tramadoli hydrochloridum - depotkapseli - 150 mg - tramadoli

TRAMADOL COPYFARM 200 mg depotkapseli 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

tramadol copyfarm 200 mg depotkapseli

copyfarm a/s - tramadoli hydrochloridum - depotkapseli - 200 mg - tramadoli

CircoMax Myco 欧盟 - 芬兰文 - EMA (European Medicines Agency)

circomax myco

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiset suidaeille - siat (lihotus) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

MILCOPEN 1500 tabletti, kalvopäällysteinen 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

milcopen 1500 tabletti, kalvopäällysteinen

takeda oy takeda oy - phenoxymethylpenicillinum kalicum - tabletti, kalvopäällysteinen - fenoksimetyylipenisilliini

MILCOPEN 1000 1 milj.IU tabletti, kalvopäällysteinen 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

milcopen 1000 1 milj.iu tabletti, kalvopäällysteinen

oy leiras finland ab - phenoxymethylpenicillinum kalicum - tabletti, kalvopäällysteinen - 1 milj.iu - fenoksimetyylipenisilliini

MILCOPEN PEDIATRIC 100000 IU/ml rakeet mikstuuraa varten 芬兰 - 芬兰文 - Fimea (Suomen lääkevirasto)

milcopen pediatric 100000 iu/ml rakeet mikstuuraa varten

oy leiras finland ab - phenoxymethylpenicillinum calcicum - rakeet mikstuuraa varten - 100000 iu/ml - fenoksimetyylipenisilliini